Makana will be participating in the UBS-sponsored Virtual Organ Restoration Day on Oct 15.?Mark Platt, Makana’s Chief Executive Officer, will be speaking at 11 am EST.?He’ll be updating the investment community on Makana’s milestones, including the company’s recent announcement that it has identified a 4th fourth gene to be inactivated in pigs that would significantly reduce organ rejection risk.?Click here to register: https://lnkd.in/g_2rTHea #Makana #Xenotransplantation
Makana Therapeutics
生物技术
Miami，Florida 966 位关注者
Transplantable cells, tissues, and organs to address today's need
关于我们
Makana Therapeutics will be exclusively focused on solving the organ shortage crisis. We are focusing on and commercializing a pipeline of transplantable cells, tissues, and organs for human patient use. Xenotransplantation is the process of transplanting organs or tissues between members of different species into humans, thus addressing the crisis of organ shortage we are facing today. Thus far, the xenotransplantation industry has been limited to cells and tissues and has yet to realize the production of organs suitable for donation.
- 网站
-
https://makanatherapeutics.com/
Makana Therapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- Miami，Florida
- 类型
- 私人持股
- 创立
- 2009
地点
-
主要
获取路线
390 NE 72nd Terrace
US，Florida，Miami，33138
Makana Therapeutics员工
动态
-
Makana? announces major breakthrough to address rejection in pig-to-human transplantation; click here to view press release https://lnkd.in/gicfHfGc #Makana #xenotransplantation
Makana News - Makana Therapeutics
https://makanatherapeutics.com
-
Makana? Therapeutics has just been granted an important patent in South Korea that will catalyze xenotransplantation efforts in that country.?Makana was granted a similar patent in Europe in 2023. The company is working to solve the organ shortage crisis by making genetically-modified pigs for use as organ donors for human recipients. The South Korean patent was granted on Makana’s Triple Knockout pig, or “TKO,” which is a combination of three xenoantigen gene knockouts in the pig that effectively camouflage the cross-species grafts from the human recipient’s immune system.?To view the press release, please visit https://lnkd.in/gicfHfGc #xenotransplantation #makanatherapeutics
Makana News - Makana Therapeutics
https://makanatherapeutics.com